Bioventus's total assets for Q4 2025 were $683.56M, a decrease of -2.57% from the previous quarter. BVS total liabilities were $455.11M for the fiscal quarter, a -7.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.